Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00073710 · ClinicalTrials.gov registry record · Phase 4
Study to Evaluate the Effects of Zemplar Injection and Calcijex on Intestinal Absorption of Calcium
A Phase 4 study, sponsored by Abbott.
- Completed
- Registry status
- Phase 4
- Development phase
- 30
- Enrollment target
NCT00073710 is a Phase 4 study that has completed, run by Abbott. The registered enrollment target is 30 participants.
The verdict
NCT00073710, a Phase 4 study, has completed, sponsored by Abbott.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 30 participants
- Enrollment target
Study Summary
A study to investigate the effects of Zemplar and Calcijex on intestinal calcium absorption in hemodialysis subjects.
Interventions
- DRUG Zemplar
- PROCEDURE 42 Ca carbonate absorption via single tracer method
- DRUG Calcijex
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2004-09 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00073710
The ClinicalTrials.gov registry entry for NCT00073710 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott, which has 181 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Zemplar is the first listed.
NCT00073710 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00073710 about?
NCT00073710 is a clinical study titled "Study to Evaluate the Effects of Zemplar Injection and Calcijex on Intestinal Absorption of Calcium". A study to investigate the effects of Zemplar and Calcijex on intestinal calcium absorption in hemodialysis subjects.
What is the current status of trial NCT00073710?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 30 participants. The study started on 2004-09.
What interventions are being tested in trial NCT00073710?
The interventions under investigation include: Zemplar (DRUG), 42 Ca carbonate absorption via single tracer method (PROCEDURE), Calcijex (DRUG).
Who is sponsoring clinical trial NCT00073710?
This trial is sponsored by Abbott, which has 181 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.